Working… Menu
Trial record 4 of 4 for:    repaglinide | Cystic Fibrosis

Diabetes Therapy to Improve BMI and Lung Function in CF

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00072904
Recruitment Status : Completed
First Posted : November 14, 2003
Last Update Posted : February 28, 2012
Cystic Fibrosis Foundation
Novo Nordisk A/S
Information provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)